Pre-pregnancy underweight and obesity are positively associated with small-for-gestational-age infants in a Chinese

Yuan Hua Chen1,2,3, Li Li4, Wei Chen5

  • 1School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China. yuanhuach@126.com.

Scientific Reports
|October 31, 2019
PubMed

Insights

Maternal pre-pregnancy underweight and obesity are linked to adverse birth outcomes. Underweight mothers have higher risks of small-for-gestational-age (SGA) infants, while obesity increases risks for both SGA and large-for-gestational-age (LGA) infants.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Public Health Nutrition

Background:

  • Suboptimal pre-pregnancy body mass index (BMI) poses risks to pregnancy outcomes.
  • The specific associations between maternal pre-pregnancy BMI categories and infant size for gestational age are not fully elucidated, particularly in diverse populations.

Purpose of the Study:

  • To investigate the relationship between pre-pregnancy BMI categories and the risk of delivering small-for-gestational-age (SGA) and large-for-gestational-age (LGA) infants.
  • To analyze these associations within a large cohort of Chinese mothers.

Main Methods:

  • A cohort study involving 12,029 pregnant women in China.
  • Participants were categorized by pre-pregnancy BMI: underweight, normal-weight, overweight, and obese.
  • Statistical analyses, including linear regression and adjusted risk ratios (RR) with 95% confidence intervals (CI), were used to assess the association between BMI and infant size for gestational age.

Main Results:

  • Birth size was reduced in underweight and obese groups compared to the normal-weight group.
  • The underweight group had a significantly higher risk of SGA infants (adjusted RR = 1.92; 95% CI: 1.61, 2.30).
  • The obese group showed significantly increased risks for both SGA (adjusted RR = 2.17; 95% CI: 1.57, 3.00) and LGA infants (adjusted RR = 3.00; 95% CI: 2.21, 4.06) compared to the normal-weight group.

Conclusions:

  • Pre-pregnancy underweight is a significant risk factor for SGA infants.
  • Maternal obesity is associated with an elevated risk of both SGA and LGA infants, highlighting a dual risk profile.
  • These findings underscore the importance of optimizing maternal pre-pregnancy BMI for improved fetal growth and pregnancy outcomes.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
182
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
208
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K